Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dry powder mannitol crossover trial in children and adolescents with cystic fibrosis
NL-OMON21839Recruiting
- Sponsor
- Pharmaxis
- Start
- Jun 2013
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised trial of Bronchitol in cystic fibrosis (CF) (2 arms), sponsored by Pharmaxis. Primary endpoint: Absolute change in percentage predicted FEV1. Started Jun 2013; status: recruiting.
02
Drugs
Bronchitol
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NL-OMON21839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21839.